LFTD Partners (LIFD) AI Stock Analysis

• Market Cap: $2.96M
• Dividend Yield: N/A
• Average Volume (3M): 1.38K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.51
• Revenue Growth: -12.70%
• EPS Growth: N/A
• Country: US
• Employees: 148
• Sector: Healthcare
• Sector Strength: 45
• Industry: Drug Manufacturers - Specialty & Generic
• EPS (TTM): N/A
• Shares Outstanding: 14,822,678
• 10 Day Avg. Volume: 3,614
• 30 Day Avg. Volume: 1,380
• PEG Ratio: >-0.01
• Price to Book (P/B): <0.01
• Price to Sales (P/S): <0.00001
• P/FCF Ratio: <0.01
• Enterprise Value/Market Cap: -3.12K
• Enterprise Value/Revenue: >-0.01
• Enterprise Value/Gross Profit: >-0.01
• Enterprise Value/Ebitda: 392.30
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 55 Neutral
• Price Target: $0.21 ▼(-31.67% Downside)
• Action: Reiterated Date: 04/01/26
• Date: Action: Reiterated 04/01/26

The score is held back primarily by highly distorted and volatile financial performance (large TTM net loss and poor comparability), partially offset by improved TTM cash generation and a conservatively levered balance sheet. Technicals are modestly constructive (slightly positive MACD, neutral RSI, strong stochastic), and the low P/E adds valuation support.

Positive Factors

Conservative leverage

Low debt relative to equity gives the company durable financial flexibility: it reduces refinancing and interest-rate risk, supports funding of R&D or commercialization, and preserves the ability to pursue strategic investments or withstand operational hiccups over the next several months.

Negative Factors

Outsized TTM net loss

A very large TTM net loss signals impaired earnings quality and raises doubt about sustainable profitability. Such outsized deterioration can reflect impairments, restructuring, or one-off charges that materially shift earnings power and complicate forecasts for several months ahead.

LFTD Partners Business Overview & Revenue Model

Company Description

LFTD Partners Inc., through its subsidiary, Lifted Made, manufactures and sells psychedelic products under its Silly Shruum brand and hemp-derived cannabinoid products under its Urb Finest Flowers brand. The company was formerly known as Acquired ...

Read more

LFTD Partners Inc., through its subsidiary, Lifted Made, manufactures and sells psychedelic products under its Silly Shruum brand and hemp-derived cannabinoid products under its Urb Finest Flowers brand. The company was formerly known as Acquired ...

LFTD Partners Financial Statement Overview

Breakdown	Dec 2025	Dec 2024	Mar 2024	Dec 2022	Mar 2022
Income Statement
Total Revenue	36.92T	37.33M	51.61M	57.42M	31.66M
Gross Profit	12.62T	12.75M	19.70M	20.99M	15.94M
EBITDA	-23.59M	-1.50M	3.35M	10.31M	7.40M
Net Income	-24.86M	-1.86M	2.16M	7.20M	5.80M
Balance Sheet
Total Assets	19.27T	47.32M	51.35M	41.13M	39.42M
Cash, Cash Equivalents and Short-Term Investments	1.77T	2.15M	4.36M	3.72M	1.60M
Total Debt	1.76T	4.51M	4.49M	1.86M	1.34M
Total Liabilities	6.64T	9.81M	12.53M	6.59M	11.96M
Stockholders Equity	12.63T	37.50M	38.82M	34.54M	27.46M
Cash Flow
Free Cash Flow	1.20T	-1.27M	-150.74K	2.12M	5.25M
Operating Cash Flow	1.32T	-960.07K	638.92K	3.04M	5.62M
Investing Cash Flow	-121.64B	-479.57K	-2.52M	-916.12K	-446.65K
Financing Cash Flow	-2.58T	-770.95K	3.70M	-193.42K	-4.01M

LFTD Partners Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.30
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Positive
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For LIFD, the sentiment is Negative. The current price of 0.3 is above the 20-day moving average (MA) of 0.24, above the 50-day MA of 0.24, and above the 200-day MA of 0.27, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 19.72 is Positive, neither overbought nor oversold. The STOCH value of 66.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for LIFD.

LFTD Partners Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
LIFD	55 Neutral	$2.96M	-0.11	-2.05%	―	-12.70%	―
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
IXHL	49 Neutral	$40.24M	-4.80	-199.09%	―	-86.05%	24.17%
YCBD	45 Neutral	$6.86M	-10.73	-40.66%	―	-1.50%	80.17%
IMCC	40 Underperform	$2.21M	-0.26	-93.87%	―	-0.74%	81.49%